相关临床试验
2
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2015
暂无试验阶段数据
已完成
1
50.0%
招募中
1
50.0%
暂无批准数据
- Scipher Medicine has launched ClinicalTrialRank.com, an AI platform that predicts clinical trial failure with unprecedented accuracy based on over 10 years of research and the human interactome network. - The platform demonstrates that poorly ranked therapeutic targets are terminated before market launch nearly 100% of the time, potentially preventing approximately 1,000 failed trials across 25 disease areas. - Built on comprehensive protein-protein interaction mapping and validated by over 100 peer-reviewed papers, the technology could redirect billions of dollars from doomed drug development programs to more promising therapeutic targets. - The multi-layered approach integrates genotype, phenotype, and treatment models to rank targets based on their relevance to disease genetics and ability to restore patients' molecular profiles to healthy states.
- Scipher Medicine and Kythera Labs have partnered to integrate clinical and genomic data from Scipher's PrismRA® Test with Kythera's multi-source EHR and claims data, achieving a 98% match rate while maintaining privacy protection. - The collaboration aims to accelerate rheumatology treatment discovery by combining Scipher's industry-leading clinico-transcriptomic rheumatology data assets with Kythera's data transformation technology. - This partnership creates a bench-to-bedside bridge that will help uncover deeper insights into autoimmune diseases and advance the development of personalized therapies for patients.
• Scipher Medicine has formed strategic partnerships with OMNY Health and Atropos Health to integrate its PrismRA test data into larger healthcare networks, creating comprehensive clinico-transcriptomic datasets for autoimmune disease research. • The OMNY Health collaboration connects Scipher's genomic insights from over 40,000 rheumatoid arthritis patients with OMNY's EHR network covering 80 million patients, enabling more targeted therapy development and improved patient outcomes. • Through the Atropos Health partnership, Scipher's precision medicine diagnostic data will enhance the Atropos Evidence Network, allowing clinicians to generate real-world evidence in minutes for personalized rheumatoid arthritis treatment decisions.
